Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine

被引：1
|
作者：
Noonan, Kimberly
Rudraraju, Lakshmi
Ferguson, Anna
Sidorski, Amy
Casildo, Andrea
Griffin, Ervin
Lee, Susan
Ghosh, Nilanjan
Matsui, William
Huff, Carol
Borrello, Ivan M.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1980.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1980
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HDAC and AKT inhibitors enhance anti-myeloma effects of daratumumab
    Hirano, Mitsuhito
    Imai, Yoichi
    Futami, Muneyoshi
    Tojo, Arinobu
    CANCER SCIENCE, 2018, 109 : 745 - 745
  • [42] Novel anti-myeloma immunotherapies targeting the SLAM family of receptors
    Radhakrishnan, Sabarinath Venniyil
    Bhardwaj, Neelam
    Luetkens, Tim
    Atanackovic, Djordje
    ONCOIMMUNOLOGY, 2017, 6 (05):
  • [43] Thalidomide metabolism and its anti-myeloma efficacy in vivo.
    Yaccoby, S
    Johnson, CL
    Mahaffey, SC
    Barlogie, B
    Epstein, J
    BLOOD, 1999, 94 (10) : 317A - 317A
  • [44] Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).
    Sanchez, Eric
    Li, Mingjie
    Wang, Cathy
    Chen, Haiming
    Berenson, James R.
    BLOOD, 2012, 120 (21)
  • [45] Anti-myeloma effects induced by myeloma idiotype pulsed dendritic cells in vitro.
    Zhang, M
    Yin, XR
    Luo, YY
    Lin, X
    He, PC
    Wang, MC
    Li, J
    Liu, YL
    Guo, GL
    Cai, RB
    Qiu, L
    BLOOD, 2005, 106 (11) : 366B - 366B
  • [46] Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Gavriatopoulou, Maria
    Kalapanida, Despoina
    Eleutherakis-Papaiakovou, Evangelos
    Roussou, Maria
    Mparmparoussi, Despoina
    Zomas, Athanasios
    Gika, Dimitra
    Kartasis, Zafiris
    Matsouka, Charis
    Kostis, Evangelos
    Kontogiannis, Sofoklis
    Konstantopoulos, Kostas
    Kastritis, Efstathios
    BLOOD, 2014, 124 (21)
  • [47] Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide
    Tateno, Shumpei
    Iida, Midori
    Fujii, Satoshi
    Suwa, Tetsufumi
    Katayama, Miki
    Tokuyama, Haruka
    Yamamoto, Junichi
    Ito, Takumi
    Sakamoto, Satoshi
    Handa, Hiroshi
    Yamaguchi, Yuki
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [48] Prophylactic broad spectrum antibiotics as a new anti-myeloma therapy
    Valkovic, Toni
    Nacinovic, Antica Duletic
    Petranovic, Duska
    MEDICAL HYPOTHESES, 2013, 81 (06) : 1137 - 1140
  • [49] Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
    Terpos, Evangelos
    Christoulas, Dimitrios
    Kastritis, Efstathios
    Migkou, Magda
    Gavriatopoulou, Maria
    Dimopoulos, Meletios-Athanassios
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S32
  • [50] NOVEL MARINE COMPOUNDS WITH ANTI-MYELOMA ACTIVITY IN VITRO AND IN VIVO
    Steiner, N.
    Untergasser, G.
    Kern, J.
    Joehrer, K.
    Seeber, A.
    Aracil, M.
    Willenbacher, W.
    Gastl, G.
    Gunsilius, E.
    HAEMATOLOGICA, 2014, 99 : 639 - 639
12345